Cited by 121Bacterial Cancer TherapyAmino Acid Enzymes and MetabolismCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction

Open access

Long, Yan, Tsai, Wen-Bin, Wangpaichitr, Medhi, Tsukamoto, Takashi, Savaraj, Niramol, Feun, Lynn G., Kuo, Macus Tien·2013·Molecular Cancer Therapeutics

DOI 10.1158/1535-7163.mct-13-0302PMC PMC3839414

Open this paper in CoChat — free account

Abstract

Many malignant human tumors, including melanomas, are auxotrophic for arginine due to reduced expression of argininosuccinate synthetase-1 (ASS1), the rate-limiting enzyme for arginine biosynthesis. Pegylated arginine deiminase (ADI-PEG20), which degrades extracellular arginine, resulting in arginine deprivation, has shown favorable results in clinical trials for treating arginine-auxotrophic tumors. Drug resistance is the major obstacle for effective ADI-PEG20 usage. To elucidate mechanisms of resistance, we established several ADI-PEG20–resistant (ADIR) variants from A2058 and SK-Mel-2 melanoma cells. Compared with the parental lines, these ADIR variants showed the following characteristics: (i) all ADIR cell lines showed elevated ASS1 expression, resulting from the constitutive binding of the transcription factor c-Myc on the ASS1 promoter, suggesting that elevated ASS1 is the major mechanism of resistance; (ii) the ADIR cell lines exhibited enhanced AKT signaling and were preferentially sensitive to PI3K/AKT inhibitors, but reduced mTOR signaling, and were preferentially resistant to mTOR inhibitor; (iii) these variants showed enhanced expression of glucose transporter-1 and lactate dehydrogenase-A, reduced expression of pyruvate dehydrogenase, and elevated sensitivity to the glycolytic inhibitors 2-deoxy-glucose and 3-bromopyruvate, consistent with the enhanced glycolytic pathway (the Warburg effect); (iv) the resistant cells showed higher glutamine dehydrogenase and glutaminase expression and were preferentially vulnerable to glutamine inhibitors. We showed that c-Myc, not elevated ASS1 expression, is involved in upregulation of many of these enzymes because knockdown of c-Myc reduced their expression, whereas overexpressed ASS1 by transfection reduced their expression. This study identified multiple targets for overcoming ADI-PEG resistance in cancer chemotherapy using recombinant arginine-degrading enzymes. Mol Cancer Ther; 12(11); 2581–90. ©2013 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-13-0302

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
The mechanism of eukaryotic translation initiation and principles of its regulation
Jackson, R. J., Hellen, C. U. T., & Pestova, T. V. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2838 · Cited by 2,759
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc882 · Cited by 1,658
Coping with stress: eIF2 kinases and translational control
Wek, R. C., Jiang, H.-Y., & Anthony, T. G. (2005) · Biochemical Society Transactions · doi:10.1042/bst0340007 · Cited by 1,353
The c-Myc target gene network
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
Genomic targets of the human c-Myc proteinPreprint
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J. R., Cocito, A., & Amati, B. B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 963

Show all 48 references

Sorted by citations

The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Nitric oxide synthase in innate and adaptive immunity: an update
Bogdan, C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.003 · Cited by 862
Regulation and metabolic functions of mTORC1 and mTORC2
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles
Minciacchi, V. R., You, S., Spinelli, C., Morley, S., Zandian, M., Aspuria, P.-J. P., Cavallini, L., Ciardiello, C., Reis-Sobreiro, M., Morello, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3598 · Cited by 419
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382
Rewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P. W., Carracedo, A., & Erez, A. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0054-z · Cited by 330
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Fendt, S., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 327
Amino Acid Depletion Therapies: Starving Cancer Cells to Death
Butler, M., van der Meer, L. T., & van Leeuwen, F. N. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.03.003 · Cited by 277
Arginine Signaling and Cancer Metabolism
Chen, C., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Cancers · doi:10.3390/cancers13143541 · Cited by 276
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 272
Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges
Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Dietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 213
Targeting the Integrated Stress Response in Cancer Therapy
Tian, X., Zhang, S., Zhou, L., Seyhan, A. A., Borrero, L. J. H., Zhang, Y., & El‐Deiry, W. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.747837 · Cited by 201
Arginine—Dual roles as an onconutrient and immunonutrient
Albaugh, V. L., Pinzon‐Guzman, C., & Barbul, A. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24490 · Cited by 173
Drug-induced amino acid deprivation as strategy for cancer therapy
Fung, M. K. L., & Chan, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0509-9 · Cited by 172
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M., Brashears, C. B., Radyk, M. D., Redlich, N. J., Tzeng, S., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 169
Self-citation
Arginine metabolism and deprivation in cancer therapy
Zou, S., Wang, X., Liu, P., Ke, C., & Xu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109210 · Cited by 165
Targeting arginine metabolism pathway to treat arginine-dependent cancers
Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
Miraki‐Moud, F., Ghazaly, E. A., Ariza‐McNaughton, L., Hodby, K. A., Clear, A. J., Anjos‐Afonso, F., Liapis, K., Grantham, M., Sohrabi, F., Cavenagh, J. D., et al. (2015) · Blood · doi:10.1182/blood-2014-10-608133 · Cited by 139
MiR-21: an environmental driver of malignant melanoma?
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0570-5 · Cited by 131
The roles of arginases and arginine in immunity
Canè, S., Geiger, R., & Bronte, V. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01098-2 · Cited by 140
SEdb 2.0: a comprehensive super-enhancer database of human and mouse
Wang, Y., Song, C., Zhao, J., Zhang, Y., Zhao, X., Feng, C., Zhang, G., Zhu, J., Wang, F., Qian, F., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac968 · Cited by 111
Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response
Ariav, Y., Ch’ng, J., Christofk, H. R., Ron‐Harel, N., & Erez, A. (2021) · Science Advances · doi:10.1126/sciadv.abg6165 · Cited by 109
Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
Matos, A., Carvalho, M., Bicho, M., & Ribeiro, R. J. T. (2021) · Nutrients · doi:10.3390/nu13124503 · Cited by 109
Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies
Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 88
Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
Pan, X.-N., Chen, J.-J., Wang, L.-X., Xiao, R.-Z., Liu, L.-L., Fang, Z.-G., Liu, Q., Long, Z., & Lin, D.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105381 · Cited by 82
Arginine deprivation in cancer therapy
Feun, L. G., Kuo, M. T., & Savaraj, N. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000122 · Cited by 84
Self-citation
A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
Lowery, M. A., Yu, K. H., Kelsen, D. P., Harding, J. J., Bomalaski, J. S., Glassman, D. C., Covington, C. M., Brenner, R., Hollywood, E. M., Barba, A., et al. (2017) · Cancer · doi:10.1002/cncr.30897 · Cited by 79
Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
Kuo, M. T., Chen, H., Feun, L. G., & Savaraj, N. (2021) · Pharmaceuticals · doi:10.3390/ph14010072 · Cited by 72
Self-citation
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor
Zou, Z., Hu, X., Luo, T., Ming, Z., Chen, X., Li, X., Luo, W., Li, J., Xu, N., Chen, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22235-8 · Cited by 70
Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer
Silberman, A., Goldman, O., Assayag, O. B., Jacob, A., Rabinovich, S., Adler, L. N., Lee, J. S., Keshet, R., Sarver, A., Frug, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1062 · Cited by 68
Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
Prudner, B. C., Rathore, R., Robinson, A. M., Godec, A., Chang, S. F., Hawkins, W. G., Hirbe, A. C., & Tine, B. A. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0206 · Cited by 66
Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines
Guo, W., Tan, H., Chen, F., Wang, N., & Feng, Y. (2020) · Cancers · doi:10.3390/cancers12020404 · Cited by 65
Polyamine Homeostasis in Development and Disease
Nakanishi, S., & Cleveland, J. L. (2021) · Medical Sciences · doi:10.3390/medsci9020028 · Cited by 68
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
Long, Y., Tsai, W.-B., Chang, J. T., Estecio, M. R., Wangpaichitr, M., Savaraj, N., Feun, L. G., Chen, H. H. W., & Kuo, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12308 · Cited by 62
Self-citation
Purification, immobilization, and biochemical characterization of l ‐arginine deiminase from thermophilic Aspergillus fumigatus KJ 434941: Anticancer activity in vitro
El‐Sayed, A. S. A., Hassan, M. N., & Nada, H. S. (2015) · Biotechnology Progress · doi:10.1002/btpr.2045 · Cited by 57
Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 57
Arginine metabolism: a potential target in pancreatic cancer therapy
Yang, J., Wang, C., Qiu, J., Ren, B., & You, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001216 · Cited by 56
The why and how of amino acid analytics in cancer diagnostics and therapy
Manig, F., Kuhne, K., von Neubeck, C., Schwarzenbolz, U., Yu, Z., Kessler, B. M., Pietzsch, J., & Kunz‐Schughart, L. A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.12.001 · Cited by 55
Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells
Yeh, T.-H., Chen, Y.-R., Chen, S., Shen, W., Ann, D. K., Zaro, J. L., & Shen, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00706 · Cited by 53
Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis
Trott, J. F., Hwang, V. J., Ishimaru, T., Chmiel, K. J., Zhou, J. X., Shim, K., Stewart, B. J., Mahjoub, M. R., Jen, K., Barupal, D. K., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2018 · Cited by 52
Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy
Long, Y., Tsai, W.-B., Wang, D., Hawke, D. H., Savaraj, N., Feun, L. G., Hung, M., Chen, H. H. W., & Kuo, M. T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.028 · Cited by 53
Self-citation
Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9
Wang, H., Li, Q., Chow, H. Y., Choi, S., & Leung, Y.-C. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00716-1 · Cited by 50
The Fate of Glutamine in Human Metabolism. The Interplay with Glucose in Proliferating Cells
Mazat, J., & Ransac, S. (2019) · Metabolites · doi:10.3390/metabo9050081 · Cited by 44
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
Savaraj, N., Wu, C., Li, Y., Wangpaichitr, M., You, M., Bomalaski, J. S., He, W., Kuo, M. T., & Feun, L. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3370 · Cited by 41
Self-citation
Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression
Kim, S. S., Xu, S., Cui, J., Poddar, S., Le, T. M., Hayrapetyan, H., Li, L., Wu, N., Moore, A. M., Zhou, L., et al. (2019) · Theranostics · doi:10.7150/thno.40195 · Cited by 40
Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1α
Lee, Y., Guo, H.-C., Zhao, G.-H., Yang, C., Chang, H.-Y., Yang, R., Chen, L., & Lee, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104581 · Cited by 38
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
Gai, X., Liu, Y., Lan, X., Chen, L., Yuan, T., Xu, J., Li, Y., Zheng, Y., Yan, Y., Yang, L., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2095 · Cited by 40
Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
Sun, N., & Zhao, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935553 · Cited by 36
A metabolic link between the urea cycle and cancer cell proliferation
Nagamani, S. C. S., & Erez, A. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1127314 · Cited by 36
Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism
Li, W., Wang, Z., Lin, R., Huang, S., Miao, H., Zou, L., Liu, K., Cui, X., Wang, Z., Zhang, Y., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115253 · Cited by 33
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
Hou, X., Chen, S., Zhang, P., Guo, D., & Wang, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.938847 · Cited by 34
Arginase purified from endophytic Pseudomonas aeruginosa IH2: Induce apoptosis through both cell cycle arrest and MMP loss in human leukemic HL-60 cells
Husain, I., Bala, K., Wani, A., Makhdoomi, U. S., Malik, F. A., & Sharma, A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.001 · Cited by 31
Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
Lu, J., Böttcher, M., Walther, T., Mougiakakos, D., Zenz, T., & Huber, W. K. (2019) · Haematologica · doi:10.3324/haematol.2018.203067 · Cited by 31
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma
Chan, P. Y., Phillips, M. M., Ellis, S. M., Johnston, A. L., Feng, X., Arora, A., Hay, G. R., Cohen, V. M. L., Sagoo, M. S., Bomalaski, J. S., et al. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13042 · Cited by 29
Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
Tsai, H., Hsiao, H., Hsu, Y., Liu, Y., Kao, H., Liu, T., Cho, S., Feng, X., Johnston, A. L., Bomalaski, J. S., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3871 · Cited by 29
Self-citation
Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
Li, Y., Wu, C., Shah, S. S., Chen, S., Wangpaichitr, M., Kuo, M. T., Feun, L. G., Han, X., Suarez, M., Prince, J. S., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12151 · Cited by 28
Self-citation
Metabolomics and proteomics reveal blocking argininosuccinate synthetase 1 alleviates colitis in mice
Liu, S., Sun, H., Du, Z., Lü, S., Wang, C., Zhang, Y., Luo, Z., Wang, L., Fan, Z., Peng, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62217-8 · Cited by 27
Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression
Tsai, W.-B., Long, Y., Chang, J. T., Savaraj, N., Feun, L. G., Jung, M., Chen, H. H. W., & Kuo, M. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11445-0 · Cited by 27
Self-citation
Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences
Kawatra, A., Dhankhar, R., & Gulati, P. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.015 · Cited by 26
Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes
Ghosh, N., Mahalanobish, S., & Sil, P. C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116326 · Cited by 26
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
Tsai, W.-B., Long, Y., Park, J.-R., Chang, J. T., Liu, H., Rodriguez‐Canales, J., Savaraj, N., Feun, L. G., Davies, M. A., Wistuba, I. I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.237 · Cited by 24
Self-citation
Pharmacologic approaches to amino acid depletion for cancer therapy
Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
Brashears, C. B., Barlin, M., Ehrhardt, W. R., Rathore, R., Schultze, M., Tzeng, S.-C., Tine, B. A. V., & Held, J. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02899-8 · Cited by 21
Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
Kuo, M. T., Long, Y., Tsai, W.-B., Li, Y.-Y., Chen, H. H. W., Feun, L. G., & Savaraj, N. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.12.003 · Cited by 21
Self-citation
Exploring the Role of Metabolites in Cancer and the Associated Nerve Crosstalk
Gu, I., Gregory, E., Atwood, C., Lee, S., & Song, Y. H. (2022) · Nutrients · doi:10.3390/nu14091722 · Cited by 20
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Li, J.-M., Chang, W., Li, L., Yang, D. C. H., Hsu, S., Kenyon, N. J., & Chen, C. (2023) · Respiratory Research · doi:10.1186/s12931-023-02421-6 · Cited by 23
Arginine Expedites Erastin-Induced Ferroptosis through Fumarate
Guo, X., Guo, Y., Li, J., Liu, Q., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914595 · Cited by 18
Extracellular Vesicles in Metabolism and Metabolic Diseases
Marzan, A. L., Nedeva, C., & Mathivanan, S. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_15 · Cited by 18
Arginine-lowering enzymes against cancer: a technocommercial analysis through patent landscape
Dhankhar, R., Gulati, P., Kumar, S., & Kapoor, R. K. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1508452 · Cited by 17
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Carpentier, J., Pavlyk, I., Mukherjee, U., Hall, P. E., & Szlosarek, P. W. (2022) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s335117 · Cited by 16
SLC7A5 is required for cancer cell growth under arginine-limited conditions
Dunlap, K., Bender, A., Bowles, A., Bott, A. J., Tay, J., Grossmann, A. H., Rutter, J. P., & Ducker, G. S. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115130 · Cited by 18
Innate and adaptive resistance mechanisms to arginine deprivation therapies in sarcoma and other cancers
Rogers, L. C., & Tine, B. A. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.49 · Cited by 17
Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas
Prudner, B. C., Sun, F., Kremer, J. C., Xu, J., Huang, C., Sai, K. K. S., Morgan, Z., Leeds, H., McConathy, J., & Tine, B. A. V. (2018) · Theranostics · doi:10.7150/thno.22083 · Cited by 14
A metabolic perspective on nitric oxide function in melanoma
Jimenez, J., Dubey, P., Carter, B., Koomen, J. M., & Markowitz, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189038 · Cited by 15
Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 14
Self-citation
Arginine deprivation as a treatment approach targeting cancer cell metabolism and survival: A review of the literature
Assi, G., & Faour, W. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175830 · Cited by 13
Cross-omics strategies and personalised options for lung cancer immunotherapy
Yan, Y., Shen, S., Li, J., Su, L., Wang, B., Zhang, J., Lu, J., Luo, H., Han, P., Ke Cheng, X. U., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1471409 · Cited by 14
Targeting the integrated stress response in ophthalmology
Chu, H.-S., Peterson, C., Jun, A. S., & Foster, J. W. (2021) · Current Eye Research · doi:10.1080/02713683.2020.1867748 · Cited by 12
Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma
Wu, C., You, M., Nguyen, D. M., Wangpaichitr, M., Li, Y., Feun, L. G., Kuo, M. T., & Savaraj, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147628 · Cited by 12
Self-citation
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy
Walts, A. E., Bomalaski, J. S., Ines, D., & Oršulić, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1904-z · Cited by 12
Cell Penetrating Peptide: Sequence-Based Computational Prediction for Intercellular Delivery of Arginine Deiminase
Zarei, M., Rahbar, M. R., Negahdaripour, M., Morowvat, M. H., Nezafat, N., & Ghasemi, Y. (2019) · Current Proteomics · doi:10.2174/1570164616666190701120351 · Cited by 11
Salubrinal Enhances Cancer Cell Death during Glucose Deprivation through the Upregulation of xCT and Mitochondrial Oxidative Stress
Chen, M., Hsu, L.-L., Wang, S., Pan, Y.-L., Lo, J., Yeh, T.-S., Tseng, L., & Lee, H. (2021) · Biomedicines · doi:10.3390/biomedicines9091101 · Cited by 12
Urea transport B gene induces melanoma B16 cell death via activation of p53 and mitochondrial apoptosis
Liu, L., Sun, Y., Zhao, Y., Wang, Q., Guo, H. B., Guo, R., Liu, Y., Fu, S., Zhang, L., Li, Y., et al. (2018) · Cancer Science · doi:10.1111/cas.13825 · Cited by 10
Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities
Javadian, P., Xu, C., Sjoelund, V. H., Borden, L. E., Garland, J., & Benbrook, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147779 · Cited by 10
The emerging roles of the urea cycle in tumor microenvironment and therapies
Zhou, J., Sun, X., & Jiang, P. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.007 · Cited by 9
Adaptation mechanisms in cancer: Lipid metabolism under hypoxia and nutrient deprivation as a target for novel therapeutic strategies (Review)
Koizume, S., & Miyagi, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13448 · Cited by 10
Therapeutic arginine starvation in ASS1-deficient cancers inhibits the Warburg effect
Kremer, J. C., & Tine, B. A. V. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1295131 · Cited by 8
Targeting nutrient metabolism with FDA-approved drugs for cancer chemoprevention: Drugs and mechanisms
Xie, Y., Yao, K., Dong, Z., & Liu, K. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.029 · Cited by 8
Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy
Zhang, J., Wang, S., Liu, H., Luo, L., & You, J. (2025) · Medicinal Research Reviews · doi:10.1002/med.70015 · Cited by 9
Arginase: Mechanisms and Clinical Application in Hematologic Malignancy
Du, Z., Li, T., Huang, J., Chen, Y., & Chen, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.905893 · Cited by 7
Bacterial stress response: understanding the molecular mechanics to identify possible therapeutic targets
Kumar, A., Rahal, A., Sohal, J. S., & Gupta, V. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1813021 · Cited by 7
Effect of glutamine metabolism on chemoresistance and its mechanism in tumors
Hu, X., Jin, H., & Zhu, L. (2021) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0040 · Cited by 10
Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis
Ji, S.-M. (2018) · médecine/sciences · doi:10.1051/medsci/201834f113 · Cited by 5
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer
Chen, D., Fan, S., Wang, J., Liang, Y., Li, P., Lv, X., Sun, Y., Wang, Q., Liu, H., Zhang, C., et al. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23507 · Cited by 5
Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium
Ibana, J. A., Cutay, S. J., Romero, M., & Schust, D. J. (2015) · Reproductive Sciences · doi:10.1177/1933719115602762 · Cited by 5
Deciphering the critical roles of the AMPK/mTOR signaling pathway in cancer cell metabolism (Review)
Alasadi, A., Fadhil, N. M., & Chen, S. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.391 · Cited by 7

Authors: Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Corresponding author: Kuo, Macus Tien
ORCID: Long, Yan
Tsai, Wen-Bin
Wangpaichitr, Medhi
Tsukamoto, Takashi
Savaraj, Niramol
Feun, Lynn G.
Venue: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Published: 2013-11-01
Volume: 12
Issue: 11
Pages: 2581-2590
ISSN: 1535-7163 (ISSN-L)
1538-8514
DOI: 10.1158/1535-7163.mct-13-0302
PMC: PMC3839414
OpenAlex: W2108745454
Cited by: 121
References: 48
Citations by year: 2026: 5 · 2025: 12 · 2024: 5 · 2023: 6 · 2022: 11 · 2021: 20 · 2020: 6 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 11 · 2014: 3 · 2013: 1
FWCI: 7.88
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Molecular Cancer Therapeutics (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK2 BX001289)
National Cancer Institute (R01CA149260, R0I-CA149260)
National Institute of Neurological Disorders and Stroke (R21NS074151)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: ADI-PEG20, melanoma, arginine auxotrophy, argininosuccinate synthetase 1, c-Myc, Akt signaling, mTOR signaling, Warburg effect, glycolysis, glutamine addiction, glutaminase, drug resistance mechanisms
MeSH terms: Arginine, Argininosuccinate Synthase, Glucose, Glutamine, Humans, Hydrolases, Lipids, Melanoma, Polyethylene Glycols, Transfection, Signal Transduction, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, Drug Resistance, Neoplasm, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks